Infectious Diseases

  • 28 November 2018

    Sun Pharmaceutical agrees to acquire Japan’s Pola Pharma

    India-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in the research, development, manufacture, and sale of branded and generic products.

  • 27 November 2018

    FDA grants ODD for AstraZeneca’s Fasenra to treat EGPA

    The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for AstraZeneca’s Fasenra (benralizumab) to treat eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that can...

  • 20 November 2018

    Roivant and iNtRON sign licensing deal for SAL200

    Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to treat infectious diseases caused by antibiotic-resistant staphylococci.

Go Top